Robert W. King

Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication

Stephanie K. Ladner, Michaël Otto, Christopher S. Barker et al. · Antimicrobial Agents and Chemotherapy · 1997 · 635 citations · Full text

Life Sciences, Biology, Molecular Biology +16

Inhibition of Human Hepatitis B Virus Replication by AT-61, a Phenylpropenamide Derivative, Alone and in Combination with (−)β- <scp>l</scp> -2′,3′-Dideoxy-3′-Thiacytidine

Robert W. King, Stephanie K. Ladner, Thomas Miller et al. · Antimicrobial Agents and Chemotherapy · 1998 · 143 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Phenylpropenamide derivatives as inhibitors of Hepatitis B virus replication

Robert B. Perni, Samuel C. Conway, Stephanie K. Ladner et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 81 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues.

Stephanie K. Ladner, Thomas Miller, Michaël Otto et al. · PubMed · 1998 · 59 citations

Life Sciences, Infectious Diseases, Molecular Biology +17

Potency of Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) Used in Combination with Other Human Immunodeficiency Virus NNRTIs, NRTIs, or Protease Inhibitors

Robert W. King, Ronald M. Klabe, Carol Reid et al. · Antimicrobial Agents and Chemotherapy · 2002 · 57 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17